Trovò M G, Tirelli U, De Paoli A, Franchin G, Roncadin M, Magri M, Galligioni E, Veronesi A, Tumolo S, Carbone A, Grigoletto E
Int J Radiat Oncol Biol Phys. 1982 Jun;8(6):1051-4. doi: 10.1016/0360-3016(82)90176-6.
Sixty-four consecutive patients with inoperable epidermoid bronchogenic carcinoma (limited disease) were treated with radiotherapy to the primary and nodal areas and combination chemotherapy with cyclophosphamide, adriamycin, methotrexate and procarbazine. The overall response rate (CR + PR) to combined treatment was 62%. The median survival time was 12.7 months. The toxicity was acceptable and no treatment-related death occurred.
